0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrointestinal Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-3O396
Home | Market Reports | Health| Health Conditions
Global Gastrointestinal Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Gastrointestinal Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-3O396
Report
September 2022
112 Pages
QYResearch
Region: Global, North America, Europe, Central & South America, Africa, Asia Pacific, Middle East
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Gastrointestinal market is projected to reach US$ 43730 million by 2028 from an estimated US$ 35990 million in 2022, at a CAGR of 3.3% during 2023 and 2028.

Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Gastrointestinal.
The Gastrointestinal market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Gastrointestinal market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria(Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Product Type Insights
Global markets are presented by Gastrointestinal type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Gastrointestinal are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Gastrointestinal Segment by Type

Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Gastrointestinal market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Gastrointestinal market.

Gastrointestinal Segment by Application

Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Gastrointestinal market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Gastrointestinal and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Gastrointestinal industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

1 Study Coverage
1.1 Gastrointestinal Product Introduction
1.2 Market by Type
1.2.1 Global Gastrointestinal Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Market Size Estimates and Forecasts
2.2 Gastrointestinal Market Size by Region: 2022 Versus 2028
2.2.1 Global Gastrointestinal Revenue by Region: 2017-2022
2.2.2 Global Gastrointestinal Revenue Forecast by Region (2023-2028)
2.2.3 Global Gastrointestinal Revenue Market Share by Region (2017-2028)
3 Global Gastrointestinal by Company
3.1 Global Gastrointestinal Revenue by Company (2017-2022)
3.2 Global Gastrointestinal Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Gastrointestinal Companies around the World: Ranking by Revenue
3.3.2 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Gastrointestinal Companies Headquarters & Product Type
3.4.1 Gastrointestinal Companies Headquarters
3.4.2 Global Gastrointestinal Companies Product & Service
3.4.3 Date of International Companies Enter into Gastrointestinal Market
3.5 Global Gastrointestinal Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 AstraZenec
4.1.1 AstraZenec Corporation Information
4.1.2 AstraZenec Description, Business Overview
4.1.3 AstraZenec Gastrointestinal Products Offered
4.1.4 AstraZenec Gastrointestinal Revenue and Gross Margin (2017-2022)
4.1.5 AstraZenec Gastrointestinal Revenue by Product in 2021
4.1.6 AstraZenec Gastrointestinal Revenue by Application in 2021
4.1.7 AstraZenec Gastrointestinal Revenue by Geographic Area in 2021
4.1.8 AstraZenec Recent Developments
4.2 Sanofi
4.2.1 Sanofi Corporation Information
4.2.2 Sanofi Description, Business Overview
4.2.3 Sanofi Gastrointestinal Products Offered
4.2.4 Sanofi Gastrointestinal Revenue and Gross Margin (2017-2022)
4.2.5 Sanofi Gastrointestinal Revenue by Product in 2021
4.2.6 Sanofi Gastrointestinal Revenue by Application in 2021
4.2.7 Sanofi Gastrointestinal Revenue by Geographic Area in 2021
4.2.8 Sanofi Recent Developments
4.3 Bayer
4.3.1 Bayer Corporation Information
4.3.2 Bayer Description, Business Overview
4.3.3 Bayer Gastrointestinal Products Offered
4.3.4 Bayer Gastrointestinal Revenue and Gross Margin (2017-2022)
4.3.5 Bayer Gastrointestinal Revenue by Product in 2021
4.3.6 Bayer Gastrointestinal Revenue by Application in 2021
4.3.7 Bayer Gastrointestinal Revenue by Geographic Area in 2021
4.3.8 Bayer Recent Developments
4.4 Pfizer
4.4.1 Pfizer Corporation Information
4.4.2 Pfizer Description, Business Overview
4.4.3 Pfizer Gastrointestinal Products Offered
4.4.4 Pfizer Gastrointestinal Revenue and Gross Margin (2017-2022)
4.4.5 Pfizer Gastrointestinal Revenue by Product in 2021
4.4.6 Pfizer Gastrointestinal Revenue by Application in 2021
4.4.7 Pfizer Gastrointestinal Revenue by Geographic Area in 2021
4.4.8 Pfizer Recent Developments
4.5 GlaxoSmithKline
4.5.1 GlaxoSmithKline Corporation Information
4.5.2 GlaxoSmithKline Description, Business Overview
4.5.3 GlaxoSmithKline Gastrointestinal Products Offered
4.5.4 GlaxoSmithKline Gastrointestinal Revenue and Gross Margin (2017-2022)
4.5.5 GlaxoSmithKline Gastrointestinal Revenue by Product in 2021
4.5.6 GlaxoSmithKline Gastrointestinal Revenue by Application in 2021
4.5.7 GlaxoSmithKline Gastrointestinal Revenue by Geographic Area in 2021
4.5.8 GlaxoSmithKline Recent Developments
4.6 Teva
4.6.1 Teva Corporation Information
4.6.2 Teva Description, Business Overview
4.6.3 Teva Gastrointestinal Products Offered
4.6.4 Teva Gastrointestinal Revenue and Gross Margin (2017-2022)
4.6.5 Teva Gastrointestinal Revenue by Product in 2021
4.6.6 Teva Gastrointestinal Revenue by Application in 2021
4.6.7 Teva Gastrointestinal Revenue by Geographic Area in 2021
4.6.8 Teva Recent Development
4.7 Zeria(Tillotts)
4.7.1 Zeria(Tillotts) Corporation Information
4.7.2 Zeria(Tillotts) Description, Business Overview
4.7.3 Zeria(Tillotts) Gastrointestinal Products Offered
4.7.4 Zeria(Tillotts) Gastrointestinal Revenue and Gross Margin (2017-2022)
4.7.5 Zeria(Tillotts) Gastrointestinal Revenue by Product in 2021
4.7.6 Zeria(Tillotts) Gastrointestinal Revenue by Application in 2021
4.7.7 Zeria(Tillotts) Gastrointestinal Revenue by Geographic Area in 2021
4.7.8 Zeria(Tillotts) Recent Development
4.8 Perrigo
4.8.1 Perrigo Corporation Information
4.8.2 Perrigo Description, Business Overview
4.8.3 Perrigo Gastrointestinal Products Offered
4.8.4 Perrigo Gastrointestinal Revenue and Gross Margin (2017-2022)
4.8.5 Perrigo Gastrointestinal Revenue by Product in 2021
4.8.6 Perrigo Gastrointestinal Revenue by Application in 2021
4.8.7 Perrigo Gastrointestinal Revenue by Geographic Area in 2021
4.8.8 Perrigo Recent Development
4.9 Boehringer Ingelheim
4.9.1 Boehringer Ingelheim Corporation Information
4.9.2 Boehringer Ingelheim Description, Business Overview
4.9.3 Boehringer Ingelheim Gastrointestinal Products Offered
4.9.4 Boehringer Ingelheim Gastrointestinal Revenue and Gross Margin (2017-2022)
4.9.5 Boehringer Ingelheim Gastrointestinal Revenue by Product in 2021
4.9.6 Boehringer Ingelheim Gastrointestinal Revenue by Application in 2021
4.9.7 Boehringer Ingelheim Gastrointestinal Revenue by Geographic Area in 2021
4.9.8 Boehringer Ingelheim Recent Development
4.10 Purdue Pharma
4.10.1 Purdue Pharma Corporation Information
4.10.2 Purdue Pharma Description, Business Overview
4.10.3 Purdue Pharma Gastrointestinal Products Offered
4.10.4 Purdue Pharma Gastrointestinal Revenue and Gross Margin (2017-2022)
4.10.5 Purdue Pharma Gastrointestinal Revenue by Product in 2021
4.10.6 Purdue Pharma Gastrointestinal Revenue by Application in 2021
4.10.7 Purdue Pharma Gastrointestinal Revenue by Geographic Area in 2021
4.10.8 Purdue Pharma Recent Development
4.11 C.B. Fleet
4.11.1 C.B. Fleet Corporation Information
4.11.2 C.B. Fleet Description, Business Overview
4.11.3 C.B. Fleet Gastrointestinal Products Offered
4.11.4 C.B. Fleet Gastrointestinal Revenue and Gross Margin (2017-2022)
4.11.5 C.B. Fleet Gastrointestinal Revenue by Product in 2021
4.11.6 C.B. Fleet Gastrointestinal Revenue by Application in 2021
4.11.7 C.B. Fleet Gastrointestinal Revenue by Geographic Area in 2021
4.11.8 C.B. Fleet Recent Development
4.12 Abbott
4.12.1 Abbott Corporation Information
4.12.2 Abbott Description, Business Overview
4.12.3 Abbott Gastrointestinal Products Offered
4.12.4 Abbott Gastrointestinal Revenue and Gross Margin (2017-2022)
4.12.5 Abbott Gastrointestinal Revenue by Product in 2021
4.12.6 Abbott Gastrointestinal Revenue by Application in 2021
4.12.7 Abbott Gastrointestinal Revenue by Geographic Area in 2021
4.12.8 Abbott Recent Development
4.13 Jiangzhong
4.13.1 Jiangzhong Corporation Information
4.13.2 Jiangzhong Description, Business Overview
4.13.3 Jiangzhong Gastrointestinal Products Offered
4.13.4 Jiangzhong Gastrointestinal Revenue and Gross Margin (2017-2022)
4.13.5 Jiangzhong Gastrointestinal Revenue by Product in 2021
4.13.6 Jiangzhong Gastrointestinal Revenue by Application in 2021
4.13.7 Jiangzhong Gastrointestinal Revenue by Geographic Area in 2021
4.13.8 Jiangzhong Recent Development
4.14 Xian-Janssen
4.14.1 Xian-Janssen Corporation Information
4.14.2 Xian-Janssen Description, Business Overview
4.14.3 Xian-Janssen Gastrointestinal Products Offered
4.14.4 Xian-Janssen Gastrointestinal Revenue and Gross Margin (2017-2022)
4.14.5 Xian-Janssen Gastrointestinal Revenue by Product in 2021
4.14.6 Xian-Janssen Gastrointestinal Revenue by Application in 2021
4.14.7 Xian-Janssen Gastrointestinal Revenue by Geographic Area in 2021
4.14.8 Xian-Janssen Recent Development
5 Breakdown Data by Type
5.1 Global Gastrointestinal Revenue by Type (2017-2022)
5.2 Global Gastrointestinal Revenue Forecast by Type (2023-2028)
5.3 Gastrointestinal Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Gastrointestinal Revenue by Application (2017-2022)
6.2 Global Gastrointestinal Revenue Forecast by Application (2023-2028)
6.3 Gastrointestinal Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Gastrointestinal Market Size YoY Growth 2017-2028
7.2 North America Gastrointestinal Market Facts & Figures by Country (2017-2028)
7.3 North America Gastrointestinal Revenue by Type (2017-2022)
7.4 North America Gastrointestinal Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Gastrointestinal Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Gastrointestinal Revenue by Type (2017-2022)
8.4 Asia-Pacific Gastrointestinal Revenue by Application (2017-2022)
9 Europe
9.1 Europe Gastrointestinal Market Size YoY Growth 2017-2028
9.2 Europe Gastrointestinal Market Facts & Figures by Country (2017-2028)
9.3 Europe Gastrointestinal Revenue by Type (2017-2022)
9.4 Europe Gastrointestinal Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Gastrointestinal Market Size YoY Growth 2017-2028
10.2 Latin America Gastrointestinal Market Facts & Figures by Country (2017-2028)
10.3 Latin America Gastrointestinal Revenue by Type (2017-2022)
10.4 Latin America Gastrointestinal Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Gastrointestinal Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Gastrointestinal Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Gastrointestinal Revenue by Type (2017-2022)
11.4 Middle East and Africa Gastrointestinal Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Gastrointestinal Supply Chain Analysis
12.2 Gastrointestinal Key Raw Materials and Upstream Suppliers
12.3 Gastrointestinal Clients Analysis
12.4 Gastrointestinal Sales Channel and Sales Model Analysis
12.4.1 Gastrointestinal Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Gastrointestinal Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Gastrointestinal Distributors
13 Market Dynamics
13.1 Gastrointestinal Industry Trends
13.2 Gastrointestinal Market Drivers
13.3 Gastrointestinal Market Challenges
13.4 Gastrointestinal Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Companies of Prescription Gastrointestinal Drug
    Table 3. Major Companies of OTC Gastrointestinal Drug
    Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Gastrointestinal Market Size by Region (US$ Million): 2022 VS 2028
    Table 6. Global Gastrointestinal Revenue by Region (2017-2022) & (US$ Million)
    Table 7. Global Gastrointestinal Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 8. Gastrointestinal Revenue by Company (2017-2022) & (US$ Million)
    Table 9. Gastrointestinal Revenue Share by Company (2017-2022)
    Table 10. Ranking of Global Top Gastrointestinal Players by Revenue (US$ Million) in 2021
    Table 11. Global Gastrointestinal Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 12. Global Gastrointestinal by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal as of 2021)
    Table 13. Global Gastrointestinal Companies Headquarters
    Table 14. Global Gastrointestinal Companies Product & Service
    Table 15. Date of International Companies Enter into Gastrointestinal Market
    Table 16. Global Gastrointestinal Mergers & Acquisitions, Expansion Plans
    Table 17. AstraZenec Corporation Information
    Table 18. AstraZenec Description and Business Overview
    Table 19. AstraZenec Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 20. AstraZenec Gastrointestinal Product
    Table 21. AstraZenec Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 22. AstraZenec Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 23. AstraZenec Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 24. AstraZenec Recent Development
    Table 25. Sanofi Corporation Information
    Table 26. Sanofi Description and Business Overview
    Table 27. Sanofi Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 28. Sanofi Gastrointestinal Product
    Table 29. Sanofi Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 30. Sanofi Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 31. Sanofi Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 32. Sanofi Recent Development
    Table 33. Bayer Corporation Information
    Table 34. Bayer Description and Business Overview
    Table 35. Bayer Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 36. Bayer Gastrointestinal Product
    Table 37. Bayer Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 38. Bayer Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 39. Bayer Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 40. Bayer Recent Development
    Table 41. Pfizer Corporation Information
    Table 42. Pfizer Description and Business Overview
    Table 43. Pfizer Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 44. Pfizer Gastrointestinal Product
    Table 45. Pfizer Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 46. Pfizer Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 47. Pfizer Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 48. Pfizer Recent Development
    Table 49. GlaxoSmithKline Corporation Information
    Table 50. GlaxoSmithKline Description and Business Overview
    Table 51. GlaxoSmithKline Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 52. GlaxoSmithKline Gastrointestinal Product
    Table 53. GlaxoSmithKline Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 54. GlaxoSmithKline Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 55. GlaxoSmithKline Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 56. GlaxoSmithKline Recent Development
    Table 57. Teva Corporation Information
    Table 58. Teva Description and Business Overview
    Table 59. Teva Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 60. Teva Gastrointestinal Product
    Table 61. Teva Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 62. Teva Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 63. Teva Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 64. Zeria(Tillotts) Corporation Information
    Table 65. Zeria(Tillotts) Description and Business Overview
    Table 66. Zeria(Tillotts) Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 67. Zeria(Tillotts) Gastrointestinal Product
    Table 68. Zeria(Tillotts) Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 69. Zeria(Tillotts) Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 70. Zeria(Tillotts) Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 71. Perrigo Corporation Information
    Table 72. Perrigo Description and Business Overview
    Table 73. Perrigo Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 74. Perrigo Gastrointestinal Product
    Table 75. Perrigo Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 76. Perrigo Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 77. Perrigo Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 78. Boehringer Ingelheim Corporation Information
    Table 79. Boehringer Ingelheim Description and Business Overview
    Table 80. Boehringer Ingelheim Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 81. Boehringer Ingelheim Gastrointestinal Product
    Table 82. Boehringer Ingelheim Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 83. Boehringer Ingelheim Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 84. Boehringer Ingelheim Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 85. Purdue Pharma Corporation Information
    Table 86. Purdue Pharma Description and Business Overview
    Table 87. Purdue Pharma Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 88. Purdue Pharma Gastrointestinal Product
    Table 89. Purdue Pharma Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 90. Purdue Pharma Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 91. Purdue Pharma Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 92. C.B. Fleet Corporation Information
    Table 93. C.B. Fleet Description and Business Overview
    Table 94. C.B. Fleet Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 95. C.B. Fleet Gastrointestinal Product
    Table 96. C.B. Fleet Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 97. C.B. Fleet Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 98. C.B. Fleet Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 99. Abbott Corporation Information
    Table 100. Abbott Description and Business Overview
    Table 101. Abbott Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 102. Abbott Gastrointestinal Product
    Table 103. Abbott Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 104. Abbott Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 105. Abbott Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 106. Jiangzhong Corporation Information
    Table 107. Jiangzhong Description and Business Overview
    Table 108. Jiangzhong Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 109. Jiangzhong Gastrointestinal Product
    Table 110. Jiangzhong Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 111. Jiangzhong Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 112. Jiangzhong Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 113. Xian-Janssen Corporation Information
    Table 114. Xian-Janssen Description and Business Overview
    Table 115. Xian-Janssen Gastrointestinal Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 116. Xian-Janssen Gastrointestinal Product
    Table 117. Xian-Janssen Gastrointestinal Revenue Proportion of Gastrointestinal by Product in 2021
    Table 118. Xian-Janssen Gastrointestinal Revenue Proportion of Gastrointestinal by Application in 2021
    Table 119. Xian-Janssen Gastrointestinal Revenue Proportion of Gastrointestinal by Geographic Area in 2021
    Table 120. Global Gastrointestinal Revenue by Type (2017-2022) & (US$ Million)
    Table 121. Global Gastrointestinal Revenue by Application (2017-2022) & (US$ Million)
    Table 122. Global Gastrointestinal Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 123. North America Gastrointestinal Revenue by Country (2017-2022) & (US$ Million)
    Table 124. North America Gastrointestinal Revenue by Country (2023-2028) & (US$ Million)
    Table 125. North America Gastrointestinal Revenue by Type (2017-2022) & (US$ Million)
    Table 126. North America Gastrointestinal Revenue by Application (2017-2022) & (US$ Million)
    Table 127. Asia-Pacific Gastrointestinal Revenue by Region (2017-2028) & (US$ Million)
    Table 128. Asia-Pacific Gastrointestinal Revenue by Region (2023-2028) & (US$ Million)
    Table 129. Asia-Pacific Gastrointestinal Revenue by Type (2017-2022) & (US$ Million)
    Table 130. Asia-Pacific Gastrointestinal Revenue by Application (2017-2022) & (US$ Million)
    Table 131. Europe Gastrointestinal Revenue by Country (2017-2022) & (US$ Million)
    Table 132. Europe Gastrointestinal Revenue by Country (2023-2028) & (US$ Million)
    Table 133. Europe Gastrointestinal Revenue by Type (2017-2022) & (US$ Million)
    Table 134. Europe Gastrointestinal Revenue by Application (2017-2022) & (US$ Million)
    Table 135. Latin America Gastrointestinal Revenue by Country (2017-2022) & (US$ Million)
    Table 136. Latin America Gastrointestinal Revenue by Country (2023-2028) & (US$ Million)
    Table 137. Latin America Gastrointestinal Revenue by Type (2017-2022) & (US$ Million)
    Table 138. Latin America Gastrointestinal Revenue by Application (2017-2022) & (US$ Million)
    Table 139. Middle East and Africa Gastrointestinal Revenue by Country (2017-2022) & (US$ Million)
    Table 140. Middle East and Africa Gastrointestinal Revenue by Country (2023-2028) & (US$ Million)
    Table 141. Middle East and Africa Gastrointestinal Revenue by Type (2017-2022) & (US$ Million)
    Table 142. Middle East and Africa Gastrointestinal Revenue by Application (2017-2022) & (US$ Million)
    Table 143. Gastrointestinal Key Raw Materials, Industry Status and Trend
    Table 144. Gastrointestinal Key Raw Materials and Upstream Suppliers
    Table 145. Gastrointestinal Clients Status and Trend
    Table 146. Gastrointestinal Typical Clients
    Table 147. Gastrointestinal Distributors
    Table 148. Gastrointestinal Market Trends
    Table 149. Gastrointestinal Market Drivers
    Table 150. Gastrointestinal Market Challenges
    Table 151. Gastrointestinal Market Restraints
    Table 152. Research Programs/Design for This Report
    Table 153. Key Data Information from Secondary Sources
    Table 154. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastrointestinal Product Picture
    Figure 2. Global Gastrointestinal Revenue Market Share by Type in 2021 & 2028
    Figure 3. Prescription Gastrointestinal Drug Product Picture
    Figure 4. OTC Gastrointestinal Drug Product Picture
    Figure 5. Global Gastrointestinal Revenue Market Share by Application in 2021 & 2028
    Figure 6. Chronic Gastritis
    Figure 7. Functional Dyspepsia
    Figure 8. Peptic Ulcer
    Figure 9. Acute Gastroenteritis
    Figure 10. Others
    Figure 11. Gastrointestinal Report Years Considered
    Figure 12. Global Gastrointestinal Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Gastrointestinal Market Size 2017-2028 (US$ Million)
    Figure 14. Global Gastrointestinal Market Size Market Share by Region: 2022 Versus 2028
    Figure 15. Global Gastrointestinal Revenue Market Share by Region (2017-2028)
    Figure 16. Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Gastrointestinal Revenue Market Share Forecast by Type (2017-2028)
    Figure 18. Global Gastrointestinal Revenue Market Share Forecast by Application (2017-2028)
    Figure 19. North America Gastrointestinal Revenue 2017-2028 (US$ Million)
    Figure 20. North America Gastrointestinal Revenue Market Share by Type (2017-2022)
    Figure 21. North America Gastrointestinal Revenue Market Share by Application (2017-2022)
    Figure 22. Asia-Pacific Gastrointestinal Revenue 2017-2028 (US$ Million)
    Figure 23. Asia-Pacific Gastrointestinal Revenue Market Share by Region (2017-2028)
    Figure 24. Asia-Pacific Gastrointestinal Revenue Market Share by Type (2017-2022)
    Figure 25. Asia-Pacific Gastrointestinal Revenue Market Share by Application (2017-2022)
    Figure 26. Europe Gastrointestinal Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 27. Europe Gastrointestinal Revenue Market Share by Country (2017-2028)
    Figure 28. Europe Gastrointestinal Revenue Market Share by Type (2017-2022)
    Figure 29. Europe Gastrointestinal Revenue Market Share by Application (2017-2022)
    Figure 30. Latin America Gastrointestinal Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 31. Latin America Gastrointestinal Revenue Market Share by Country (2017-2022)
    Figure 32. Latin America Gastrointestinal Revenue Market Share by Type (2017-2022)
    Figure 33. Latin America Gastrointestinal Revenue Market Share by Application (2017-2022)
    Figure 34. Middle East and Africa Gastrointestinal Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 35. Middle East and Africa Gastrointestinal Revenue Market Share by Country (2017-2028)
    Figure 36. Middle East and Africa Gastrointestinal Revenue Market Share by Type (2017-2022)
    Figure 37. Middle East and Africa Gastrointestinal Revenue Market Share by Application (2017-2022)
    Figure 38. Gastrointestinal Supply Chain (Upstream and Downstream Market)
    Figure 39. Global Production Market Share of Gastrointestinal Raw Materials by Region in 2021
    Figure 40. Gastrointestinal Distribution Channels
    Figure 41. Global Gastrointestinal Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 42. Global Gastrointestinal Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 43. Bottom-up and Top-down Approaches for This Report
    Figure 44. Data Triangulation
    Figure 45. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Global ECG Monitoring Electrodes Market Research Report 2022
Global ECG Monitoring Electrodes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-37J10807
Mon Oct 24 00:00:00 UTC 2022

Add to Cart

Add to Cart

Global Human Vaccine Adjuvants Market Insights and Forecast to 2028
Global Human Vaccine Adjuvants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-16A8759
Mon Oct 24 00:00:00 UTC 2022

Add to Cart